ストックスクリーナーアプリを入手
295.68
0.18%
-0.14
前日終値:
$295.54
開ける：
$295.79
24時間の取引高:
47,816
Relative Volume:
0.02
時価総額：
$159.01B
収益：
$34.76B
当期純損益:
$6.62B
株価収益率:
24.19
EPS:
12.223
ネットキャッシュフロー:
$10.61B
1週間 パフォーマンス:
-1.17%
1か月 パフォーマンス:
+5.29%
6か月 パフォーマンス:
+5.26%
1年 パフォーマンス:
-7.14%
1日の値動き範囲:
$294.56
$296.38
1週間の範囲:
$290.21
$301.54
52週間の値動き範囲:
$253.30
$335.88
Amgen Inc Stock (AMGN) Company Profile
AMGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
295.35 | 159.11B | 34.76B | 6.62B | 10.61B | 12.22 |
|
LLY
Lilly Eli Co
|
849.72 | 756.28B | 53.26B | 13.80B | -50.20M | 15.08 |
|
JNJ
Johnson Johnson
|
188.81 | 454.91B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
230.95 | 411.31B | 58.33B | 3.73B | 18.24B | 2.1013 |
|
NVS
Novartis Ag Adr
|
132.80 | 254.66B | 53.40B | 13.68B | 16.89B | 6.8864 |
|
MRK
Merck Co Inc
|
87.41 | 218.83B | 63.43B | 16.42B | 14.72B | 6.4861 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-03 | 再開されました | Raymond James | Mkt Perform |
| 2025-05-20 | 再開されました | Guggenheim | Neutral |
| 2025-04-22 | 再開されました | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 再開されました | BofA Securities | Underperform |
| 2024-11-15 | 開始されました | Wolfe Research | Peer Perform |
| 2024-11-14 | 開始されました | Citigroup | Neutral |
| 2024-10-17 | 開始されました | Bernstein | Outperform |
| 2024-10-14 | ダウングレード | Truist | Buy → Hold |
| 2024-09-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-08-07 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | アップグレード | Barclays | Underweight → Equal Weight |
| 2024-05-03 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | 再開されました | Raymond James | Mkt Perform |
| 2024-02-07 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | アップグレード | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 開始されました | Deutsche Bank | Hold |
| 2023-11-02 | アップグレード | Truist | Hold → Buy |
| 2023-10-20 | 再開されました | JP Morgan | Neutral |
| 2023-10-17 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-10-11 | 再開されました | BofA Securities | Neutral |
| 2023-09-06 | 開始されました | HSBC Securities | Buy |
| 2023-04-24 | 繰り返されました | Oppenheimer | Outperform |
| 2023-03-13 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | 繰り返されました | Truist | Buy |
| 2022-11-18 | 開始されました | Credit Suisse | Underperform |
| 2022-10-31 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2022-10-11 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | 開始されました | SVB Leerink | Mkt Perform |
| 2022-02-09 | 繰り返されました | Barclays | Equal Weight |
| 2022-02-09 | 繰り返されました | Jefferies | Buy |
| 2022-02-09 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2022-02-09 | 繰り返されました | Oppenheimer | Outperform |
| 2022-02-09 | 繰り返されました | Wells Fargo | Equal Weight |
| 2022-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-12-09 | 再開されました | Wells Fargo | Equal Weight |
| 2021-12-06 | 開始されました | Goldman | Buy |
| 2021-11-19 | 開始されました | BMO Capital Markets | Market Perform |
| 2021-09-23 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | 開始されました | Daiwa Securities | Buy |
| 2020-10-28 | 開始されました | UBS | Neutral |
| 2020-10-26 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | アップグレード | Truist | Hold → Buy |
| 2020-10-09 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | ダウングレード | Truist | Buy → Hold |
| 2020-10-08 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | 再開されました | Guggenheim | Neutral |
| 2020-03-31 | 開始されました | Wolfe Research | Peer Perform |
| 2020-03-30 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | 開始されました | Barclays | Equal Weight |
| 2020-01-31 | ダウングレード | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-12-24 | 開始されました | Raymond James | Mkt Perform |
| 2019-12-17 | 再開されました | Morgan Stanley | Overweight |
| 2019-11-12 | 開始されました | SunTrust | Buy |
| 2019-11-05 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | 再開されました | BofA/Merrill | Neutral |
| 2019-08-19 | ダウングレード | Mizuho | Buy → Neutral |
| 2019-05-23 | アップグレード | Citigroup | Neutral → Buy |
すべてを表示
Amgen Inc (AMGN) 最新ニュース
Dohj LLC Grows Stock Position in Amgen Inc. $AMGN - MarketBeat
Castle Rock Wealth Management LLC Acquires 2,931 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN is WoodTrust Financial Corp's Largest Position - MarketBeat
BankPlus Trust Department Raises Stock Position in Amgen Inc. $AMGN - MarketBeat
Shell Asset Management Co. Acquires 7,440 Shares of Amgen Inc. $AMGN - MarketBeat
The Technical Signals Behind (AMGN) That Institutions Follow - news.stocktradersdaily.com
(AMGN) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
Destiny Wealth Sells $8.1 Million in IBB Shares — Here’s Why Biotech Stocks Are Lagging - The Motley Fool
Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syn - PharmiWeb.com
Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60% - Yahoo Finance
(AMGN) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Amgen price collects profitsForecast today07-10-2025 - Economies.com
Amgen Inc. $AMGN Shares Acquired by Godsey & Gibb Inc. - MarketBeat
Amgen Inc. $AMGN Shares Sold by Country Club Bank - MarketBeat
KLP Kapitalforvaltning AS Buys 8,500 Shares of Amgen Inc. $AMGN - MarketBeat
Simplicity Wealth LLC Has $1.43 Million Holdings in Amgen Inc. $AMGN - MarketBeat
SteelPeak Wealth LLC Raises Holdings in Amgen Inc. $AMGN - MarketBeat
Discipline and Rules-Based Execution in AMGN Response - news.stocktradersdaily.com
Precision Trading with Amgen Inc. (AMGN) Risk Zones - news.stocktradersdaily.com
AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S. - PR Newswire
Amgen (AMGN) Stock Sinks As Market Gains: Here's Why - sharewise.com
Why (AMGN) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms - The American Journal of Managed Care® (AJMC®)
Amgen Inc. (AMGN) Stock: Dips Amid Bold Repatha Price Cut by 60% and Direct Sales Launch - parameter.io
Amgen (AMGN) Shares Fall Following Discounted Drug Pricing Annou - GuruFocus
Amgen Slashes Drug Price After Trump Threat--Repatha Now 60% Cheaper Online - Yahoo
Amgen Slashes Drug Price After Trump Threat--Repatha Now 60% Che - GuruFocus
Amgen To Offer Cholesterol Drug At 60% Discount As Trump Administration's Call To Lower Drug Prices - Benzinga
Amgen Joins Direct-To-Patient Rush With Repatha Program - insights.citeline.com
Amgen to sell cholesterol drug at 60% discount to cash-paying US patients - Reuters
Amgen (AMGN) Reduces Price for Cholesterol Drug Repatha - GuruFocus
Amgen to offer Repatha at 60% discount to U.S. consumers - Seeking Alpha
Amgen Lowers Cholesterol-Medication Price After Trump Call for Price Cuts - The Wall Street Journal
Does Amgen’s Recent 8.7% Surge Signal a Sustainable Opportunity for 2025 Investors? - simplywall.st
Amgen (AMGN) Launches AmgenNow with Affordable Pricing for Repat - GuruFocus
Amgen makes Repatha available at nearly 60% discount via direct program - Investing.com Canada
Will Amgen Inc. (AMG0) stock deliver stable dividendsEarnings Risk Summary & Precise Entry and Exit Recommendations - newser.com
Amgen Offers 60% Discount on Repatha Following Trump’s Drug Price Cut Demands - Quiver Quantitative
Amgen To Sell Cholesterol Drug For Approximately 60% Discount - Stocktwits
(AMGN) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Will Amgen Inc. (AMG0) stock outperform energy sector in 20252025 Big Picture & Safe Entry Momentum Tips - newser.com
Amgen to sell cholesterol drug at 60% discount direct to US consumers - MarketScreener
Is There An Opportunity With Amgen Inc.'s (NASDAQ:AMGN) 49% Undervaluation? - Yahoo
New Amgen Website Offers Repatha at 60% Off After Trump Pressure - Bloomberg.com
Short interest data insights for Amgen Inc.July 2025 Patterns & Technical Confirmation Trade Alerts - newser.com
Valeo Financial Advisors LLC Has $12.66 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Merit Financial Group LLC Has $6.79 Million Stake in Amgen Inc. $AMGN - MarketBeat
OLD National Bancorp IN Purchases 13,460 Shares of Amgen Inc. $AMGN - MarketBeat
Price-Driven Insight from (AMGN) for Rule-Based Strategy - news.stocktradersdaily.com
Behavioral Patterns of AMGN and Institutional Flows - news.stocktradersdaily.com
Understanding Momentum Shifts in (AMGN) - news.stocktradersdaily.com
Amgen Inc (AMGN) 財務データ
収益
当期純利益
現金流量
EPS
0.21%
0.22%
大文字化:
|
ボリューム (24 時間):